Oxygen Biotherapeutics, Inc., (Nasdaq: OXBT) announced its intention, subject to market and other conditions, to commence a public offering of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE